Illuminating Preclinical Translation of a Nanoparticle-Based Active Antigen-Specific Immune Tolerance Platform
Time: 3:15 pm
day: Conference Day Two
Details:
- Discussing the nanoparticle pMHC-delivered tolerance approach
- Using humanized mouse models to translate to the clinic
